Psoriatic arthritis (PsA) is a serious and potentially disabling condition that affects about 30% of patients with psoriasis. The joint involvement of PsA often occurs about 10 years after the appearance of skin disease. In addition to the physical and functional impairments from joint destruction, PsA negatively impacts relationships, activities of daily living, work productivity, and overall quality of life (QoL). Unfortunately, individuals with PsA are often undiagnosed or misdiagnosed. Dermatologists clearly have an important role in detecting early signs of PsA, and the overlapping treatment needs of patients often require collaborative care between dermatologists and rheumatologists. This Psoriatic Arthritis Hub is dedicated to providing educational activities, resources, and tools to improve the care of patients with PsA.
The final installment of this CME Outfitters Snack series on managing PsA features discussion on the incorporation of patient-reported outcomes into shared decision-making, employing a multidisciplinary approach to coordination of care, and how best to monitor patients with PsO for PsA at each visit.
The first episode of this CME Outfitters Snack series on the evolving treatment landscape for PsA features expert faculty describing clinically relevant pathophysiologic processes that contribute to the development of psoriatic arthritis in order to facilitate proper screening and faster diagnosis of patients with PsA.